News | December 21, 2025
The initiative is focused on a problem that continues to plague cancer outcomes in India
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
The move strengthens GBL’s clinical-stage presence in the United States
The company shall process the change of name application with BSE Ltd. in due course
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Clinical trial enrollment has long been a bottleneck in drug development
Subscribe To Our Newsletter & Stay Updated
